Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.

Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, Twilt M, Benseler SM, Campillo S, Charuvanij S, Dancey P, Eberhard BA, Elder ME, Hersh A, Higgins GC, Huber AM, Khubchandani R, Kim S, Klein-Gitelman M, Kostik MM, Lawson EF, Lee T, Lubieniecka JM, McCurdy D, Moorthy LN, Morishita KA, Nielsen SM, O'Neil KM, Reiff A, Ristic G, Robinson AB, Sarmiento A, Shenoi S, Toth MB, Van Mater HA, Wagner-Weiner L, Weiss JE, White AJ, Yeung RS; ARChiVe Investigators Network within the PedVas Initiative..

Arthritis Rheumatol. 2016 Oct;68(10):2514-26. doi: 10.1002/art.39729.

PMID:
27111558
2.

Prescription patterns for children with juvenile idiopathic arthritis in Michigan Medicaid: a comparison by prescriber type.

Riebschleger MP, Van Mater HA, Cohn LM, Clark SJ.

Pediatr Rheumatol Online J. 2014 Sep 5;12:38. doi: 10.1186/1546-0096-12-38.

3.

Pediatric inflammatory brain diseases: a diagnostic approach.

Van Mater H.

Curr Opin Rheumatol. 2014 Sep;26(5):553-61. doi: 10.1097/BOR.0000000000000092. Review.

PMID:
25050924
4.

Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.

Morishita K, Guzman J, Chira P, Muscal E, Zeft A, Klein-Gitelman M, Uribe AG, Abramson L, Benseler SM, Eberhard A, Ede K, Hashkes PJ, Hersh AO, Higgins G, Imundo LF, Jung L, Kim S, Kingsbury DJ, Lawson EF, Lee T, Li SC, Lovell DJ, Mason T, McCurdy D, O'Neil KM, Punaro M, Ramsey SE, Reiff A, Rosenkranz M, Schikler KN, Scuccimarri R, Singer NG, Stevens AM, van Mater H, Wahezi DM, White AJ, Cabral DA; ARChiVe Investigators Network..

J Rheumatol. 2012 Oct;39(10):2012-20. doi: 10.3899/jrheum.120299.

PMID:
22859342
5.

Systematic review of disease-modifying antirheumatic drugs for juvenile idiopathic arthritis.

Kemper AR, Van Mater HA, Coeytaux RR, Williams JW Jr, Sanders GD.

BMC Pediatr. 2012 Mar 15;12:29. doi: 10.1186/1471-2431-12-29. Review.

6.

Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) [Internet].

Kemper AR, Coeytaux R, Sanders GD, Van Mater H, Williams JW, Gray RN, Irvine RJ, Kendrick A.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Sep.

7.

Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference.

Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, Curran M, Feldman BM, Gewanter H, Griffin T, Haines K, Hoeltzel MF, Isgro J, Kahn P, Lang B, Lawler P, Shaham B, Schmeling H, Scuccimarri R, Shishov M, Stringer E, Wohrley J, Ilowite NT, Wallace C; Juvenile Dermatomyositis Subcommittee of the Childhood Arthritis and Rheumatology Research Alliance..

Arthritis Care Res (Hoboken). 2012 Apr;64(4):546-53. doi: 10.1002/acr.20695.

8.

Psychometric characteristics of outcome measures in juvenile idiopathic arthritis: a systematic review.

van Mater HA, Williams JW Jr, Coeytaux RR, Sanders GD, Kemper AR.

Arthritis Care Res (Hoboken). 2012 Apr;64(4):554-62. doi: 10.1002/acr.20667. Review.

Items per page

Supplemental Content

Loading ...
Support Center